EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular basis of linezolid resistance in Finegoldia spp. from orthopedic infections

Vincent Jean-Pierre iD, Mikeldi Moulieras, Alix Pantel iD, Fabien Aujoulat, Jean-Philippe Lavigne iD, Agathe Boudet, Hélène Marchandin iD

Antimicrobial Agents and Chemotherapy · 01.04.2026 · 70 (4)

DOI: 10.1128/aac.01702-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.04.2026. Verfasst von Vincent Jean-Pierre und 6 weiteren Autor:innen. Beteiligte Einrichtung: HydroSciences Montpellier, Université Montpellier, CNRS, IRD, Service de Microbiologie et Hygiène Hospitalière, CHU de Nîmes, Montpellier, France. Hauptthemen laut MEDLINE: Linezolid, Anti-Bacterial Agents, Drug Resistance, Bacterial, Bacillota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Finegoldia spp. are Gram-positive anaerobic cocci increasingly recognized as opportunistic pathogens, particularly in bone infections. Linezolid (LZD), an oxazolidinone with activity against anaerobes, is frequently used in orthopedic infections but is subject to various resistance mechanisms. Here, we characterized the molecular basis of LZD resistance in Finegoldia sp. isolates from three separate cases of bone infection. Antimicrobial susceptibility testing (AST) was performed according to Antibiotic Susceptibility Committee of the French Society of Microbiology (CA-SFM) recommendations. Whole-genome sequences were analyzed to challenge mass spectrometry identification (ANIb, is DDH), determine isolate relatedness (SNP analysis), and characterize the genetic support of resistance (ABRicate, AMRFinderPlus). LZD-resistant strains were isolated following LZD treatment in all three patients. In one case, low SNP divergence between susceptible and resistant isolates supported in vivo emergence of resistance. Genomic analyses suggested that the strains probably belong to undescribed Finegoldia species. LZD resistance was mediated by the cfr (C) gene encoding a 23S rRNA methyltransferase, and in two isolates with high-level resistance, was associated with a G71D mutation in the ribosomal protein L4-encoding gene. The cfr (C) gene was located on two distinct integrative and conjugative elements closely related to ones previously described in Clostridioides difficile and Faecalibacterium taiwanense . In anaerobes, LZD resistance remains rarely reported in the literature, except in non- fragilis Bacteroides species. However, LZD resistance in the Finegoldia genus highlighted in this study supports the need for systematic AST of Finegoldia sp. isolates, particularly in polymicrobial infections, when LZD is considered for the treatment. If LZD is ineffective, tedizolid testing may be suggested as a potential therapeutic alternative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidAnti-Bacterial AgentsDrug Resistance, BacterialBacillotaMicrobial Sensitivity TestsHumansRibosomal ProteinsRNA, Ribosomal, 23SMethyltransferasesPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Finegoldia sp.anaerobesbone infectioncfr(C) geneintegrative and conjugative elements (ICE)linezolidresistance

Substanzen

LinezolidAnti-Bacterial AgentsRibosomal ProteinsRNA, Ribosomal, 23SMethyltransferasesribosomal protein L4

Autor:innen und Institutionen

  • HydroSciences Montpellier, Université Montpellier, CNRS, IRD, Service de Microbiologie et Hygiène Hospitalière, CHU de Nîmes, Montpellier, France.
  • Service de Microbiologie et Hygiène Hospitalière, Université Montpellier, CHU Nîmes, Nîmes, France.
  • VBIC, INSERM U1047, Université Montpellier, Service de Microbiologie et Hygiène Hospitalière, Plateforme MICRO&BIO, CHU Nîmes, Nîmes, France.
  • HydroSciences Montpellier, Université Montpellier, CNRS, IRD, Nîmes, France.

ORCID-Profile: Vincent Jean-Pierre, Alix Pantel, Jean-Philippe Lavigne, Hélène Marchandin

Zitieren

APA

Jean-Pierre, V., Moulieras, M., Pantel, A., Aujoulat, F., Lavigne, J. P., Boudet, A., & Marchandin, H. (2026). Molecular basis of linezolid resistance in Finegoldia spp. from orthopedic infections. Antimicrobial Agents and Chemotherapy, 70(4). https://doi.org/10.1128/aac.01702-25

Vancouver

Jean-Pierre V, Moulieras M, Pantel A, Aujoulat F, Lavigne JP, Boudet A, et al. Molecular basis of linezolid resistance in Finegoldia spp. from orthopedic infections. Antimicrobial Agents and Chemotherapy. 2026;70(4). doi:10.1128/aac.01702-25

BibTeX
@article{JeanPierre2026,
  author = {Jean-Pierre, Vincent and Moulieras, Mikeldi and Pantel, Alix and Aujoulat, Fabien and Lavigne, Jean-Philippe and Boudet, Agathe and Marchandin, Hélène},
  title = {Molecular basis of linezolid resistance in Finegoldia spp. from orthopedic infections},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {4},
  doi = {10.1128/aac.01702-25}
}
Kostenlos starten →